Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Sirolimus for the Treatment of the Autoimmune Blistering Dermatosis Pemphigus

NCT01313923 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT01313923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01313923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Sirolimus for the Treatment of the Autoimmune Blistering Dermatosis Pemphigus
Lead sponsor
University of California, Irvine
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2011
Completion date
October 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus